A
Artizan Biosciences
Pioneering precision therapeutics that neutralize microbial triggers to restore intestinal health to treat diseases
About Artizan Biosciences
Artizan Biosciences, Inc. is a biotechnology company focused on developing microbiome-based therapies to treat chronic diseases. The company leverages cutting-edge research from Yale Immunobiology faculty members to create precision medicine solutions that target the root causes of various chronic conditions. Artizan Biosciences operates in the biopharmaceutical market, primarily serving healthcare providers and patients who suffer from chronic diseases. The business model revolves around research and development, clinical trials, and eventual commercialization of its proprietary therapies. Revenue is generated through partnerships, grants, and future sales of approved treatments. The company aims to revolutionize the treatment landscape by offering targeted, effective, and personalized medical solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 63.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Marketplace & ecommerce
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jun 2022 | $19M | $76M | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Mar 2021 | $11M | $60M | Connecticut Innovations · Elm Street Ventures · Osage University Partners · Biohaven | — |
Growth signals
Latest recorded traffic for Artizan Biosciences is 220 monthly website visits, down 99.5% over the last three months. Artizan Biosciences's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Artizan Biosciences in the New Haven ecosystem
The Artizan Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Connecticut Innovations- EVElm Street Ventures
Osage University Partners
Biohaven
Hatteras Venture Partners
Other known investors2 additional known investors
Yale University
Yale Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Artizan Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Artizan Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










